Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Insight Molecular Diagnostics (IMDX) Income towards Parent Company (2020 - 2025)

Historic Income towards Parent Company for Insight Molecular Diagnostics (IMDX) over the last 6 years, with Q3 2025 value amounting to -$11.0 million.

  • Insight Molecular Diagnostics' Income towards Parent Company rose 1825.38% to -$11.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$61.3 million, marking a year-over-year decrease of 12479.84%. This contributed to the annual value of -$61.0 million for FY2024, which is 198615.86% down from last year.
  • According to the latest figures from Q3 2025, Insight Molecular Diagnostics' Income towards Parent Company is -$11.0 million, which was up 1825.38% from -$9.8 million recorded in Q2 2025.
  • Over the past 5 years, Insight Molecular Diagnostics' Income towards Parent Company peaked at -$2.9 million during Q1 2023, and registered a low of -$35.7 million during Q4 2021.
  • Its 5-year average for Income towards Parent Company is -$13.5 million, with a median of -$10.1 million in 2022.
  • As far as peak fluctuations go, Insight Molecular Diagnostics' Income towards Parent Company plummeted by 43856.95% in 2021, and later surged by 7156.74% in 2023.
  • Insight Molecular Diagnostics' Income towards Parent Company (Quarter) stood at -$35.7 million in 2021, then grew by 7.65% to -$33.0 million in 2022, then skyrocketed by 91.12% to -$2.9 million in 2023, then plummeted by 1049.25% to -$33.6 million in 2024, then surged by 67.15% to -$11.0 million in 2025.
  • Its last three reported values are -$11.0 million in Q3 2025, -$9.8 million for Q2 2025, and -$6.8 million during Q1 2025.